Evidence map›Paper›PMID 40502661›Full record

ArticleData in brief2025

Diagnosis of rheumatic and autoimmune diseases dataset.

Mohammed Fadhil Mahdi, Arezoo Jahani, Dhafar Hamed Abd

Abstract read
In one paragraph

Article in Data in brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohammed Fadhil MahdiFaculty of Electrical and Computer Engineering, Sahand University of Technology, Tabriz, Iran.
Arezoo JahaniFaculty of Electrical and Computer Engineering, Sahand University of Technology, Tabriz, Iran.
Dhafar Hamed AbdCollege of Computer Science and Information Technology University of Anbar Ramadi, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study presents a primary dataset collected from one hospital and three laboratories in Iraq between 2019 and 2024. The dataset includes both the case and control groups, the case group comprising patients diagnosed with six common rheumatic and autoimmune diseases: rheumatoid arthritis, reactive arthritis, ankylosing spondylitis, Sjögren syndrome, systemic lupus erythematosus, and psoriatic arthritis. The dataset contains records of 12,085 patients with rheumatic and autoimmune diseases. Patient privacy is ensured through data anonymization. The dataset includes 14 features in seven classes, aiding the development of machine learning models for the early and accurate diagnosis of rheumatic and autoimmune diseases. This dataset is valuable for clinical decision support, remote healthcare, drug development, and medical diagnosis. It facilitates early diagnosis, supports explainable artificial intelligence models, advances precision medicine, enhances research, and reduces diagnostic costs and time.

Indexed as

Ankylosing spondylitisPsoriatic arthritisReactive arthritisRheumatoid arthritisSjögren syndromeSystemic lupus erythematosus

Identifiers

PMID40502661
PMCPMC12152559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.